Autism spectrum disorder (ASD) is a complex neurodevelopmental condition characterized by social communication deficits, restricted interests, and heightened anxiety. While mouse models have been essential for identifying molecular and neural mechanisms of ASD, their translational value is limited by major differences in brain organization, social cognition, and behavior compared with humans.
To overcome these limitations, researchers led by Rui Tian, Yuan Li, and colleagues developed the first genetically engineered canine model of ASD by targeting the SHANK3 gene, one of the most consistently replicated genetic risk factors identified in human ASD. SHANK3 encodes a synaptic scaffolding protein essential for excitatory synapse development and neural circuit stability.
Using CRISPR/Cas9 gene editing, the team generated multiple independent lines of Beagle Shank3 (bShank3) mutant dogs, which were successfully propagated across several generations. This achievement demonstrates the feasibility of producing a large cohort of genetically modified dogs within a practical time frame, a key advantage over non-human primate models.
The researchers developed and validated a standardized battery of behavioral assays tailored for controlled canine experiments. Across multiple tests, bShank3 mutant dogs showed robust and consistent behavioral abnormalities, including social withdrawal, markedly reduced interaction with humans, and elevated anxiety in novel or challenging environments. These traits were observed across a large sample size (n = 44 mutants) and contrasted with wild-type controls (n = 27).
Importantly, the observed deficits closely parallel core social and emotional features of human ASD, particularly impairments in social engagement rather than simple motor or sensory abnormalities. This distinction strengthens the model’s relevance for studying higher-order social cognition and emotional regulation.
Beyond behavior, dogs offer additional translational advantages. Canines share closer brain anatomy, more complex social communication, and drug metabolism profiles that are more comparable to humans than rodents. Unlike non-human primates, dogs also have a shorter reproductive cycle, larger litter sizes, and lower maintenance costs, making them more accessible for preclinical research.
The authors conclude that the bShank3 canine model represents a powerful new platform for investigating the pathophysiology of ASD, testing pharmacological and behavioral interventions, and exploring gene–environment interactions underlying psychiatric disorders. More broadly, this work positions dogs as a valuable and underutilized species for translational neuroscience and precision psychiatry.
**Source:** Tian, R., Li, Y., et al. (2023). Modeling SHANK3-associated autism spectrum disorder in Beagle dogs via CRISPR/Cas9 gene editing. Molecular Psychiatry.
